REGENERX BIOPHARMACEUTICALS INC·4

Jul 19, 5:13 PM ET

MCNAY JOSEPH C 4

4 · REGENERX BIOPHARMACEUTICALS INC · Filed Jul 19, 2018

Insider Transaction Report

Form 4
Period: 2018-07-17
Transactions
  • Award

    Stock Option (Right to Buy)

    2018-07-17$0.21/sh+200,000$42,000200,000 total
    Exercise: $0.21Exp: 2028-07-17Common Stock (200,000 underlying)
Holdings
  • Common Stock

    3,912,722
Footnotes (1)
  • [F1]The option vests in four equal installments of 50,000 shares on each of July 17, 2018, 2019, 2020 and 2021.

Documents

1 file
  • 4
    edgar.xmlPrimary

    PRIMARY DOCUMENT